Pacira BioSciences (PCRX) Goodwill & Intangibles (2010 - 2026)

Pacira BioSciences' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $373.0 million for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 18.29% year-over-year to $373.0 million in Q1 2026; TTM through Mar 2026 was $373.0 million, a 18.29% decrease from a year earlier, with the FY2025 full-year figure at $388.3 million, down 8.84% from the prior year.
• Goodwill & Intangibles fell to $373.0 million in Q1 2026 per PCRX's latest filing, from $388.3 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $755.4 million in Q1 2022 and bottomed at $373.0 million in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $632.2 million (2024), against an average of $575.9 million.
• Across the five-year window, Goodwill & Intangibles soared 289.26% in 2022 and sank 34.11% in 2024, its largest moves.
• Year by year, Goodwill & Intangibles stood at $703.7 million in 2022, then declined by 8.13% to $646.5 million in 2023, then sank by 34.11% to $426.0 million in 2024, then dropped by 8.84% to $388.3 million in 2025, then fell by 3.94% to $373.0 million in 2026.
• Per Business Quant, the three latest PCRX Goodwill & Intangibles figures stand at $373.0 million (Q1 2026), $388.3 million (Q4 2025), and $402.7 million (Q3 2025).